Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Campylobacter pylori: a new pathogen.

S J Czinn1, W T Speck

  • 1Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Advances in Pediatric Infectious Diseases
|January 1, 1990
PubMed
Summary

Helicobacter pylori (C. pylori) is a human pathogen linked to gastroduodenal diseases. Current treatments eradicate the infection in about 50% of patients, with further antimicrobial therapy recommended for persistent symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatrician and Caregiver Awareness of Cryptosporidiosis and Giardiasis in Children: US Survey Responses.

Zoonoses and public health·2015
Same author

Gastric LTi cells promote lymphoid follicle formation but are limited by IRAK-M and do not alter microbial growth.

Mucosal immunology·2015
Same author

Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial.

Alimentary pharmacology & therapeutics·2003
Same author

Portal vein gas associated with rotavirus infection.

Journal of pediatric gastroenterology and nutrition·2001
Same author

Helicobacter pylori acquisition and transmission: where does it all begin?

Gastroenterology·2001
Same author

Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization.

The Journal of infectious diseases·2001

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pathogen Research

Background:

  • Growing evidence implicates *C. pylori* as a significant human pathogen.
  • A well-established correlation exists between *C. pylori* infection and gastroduodenal disease.
  • Pathogenic mechanisms proposed include cytotoxin production and epithelial disruption.

Purpose of the Study:

  • To review the evidence for *C. pylori* as a human pathogen.
  • To discuss proposed mechanisms of *C. pylori*-induced gastroduodenal disease.
  • To evaluate current treatment strategies for *C. pylori* infection.

Main Methods:

  • Literature review of studies on *C. pylori* and gastroduodenal disease.
  • Analysis of proposed pathogenic mechanisms.
  • Assessment of antimicrobial treatment efficacy.

Main Results:

  • *C. pylori* is strongly associated with gastroduodenal disease.
  • Current combination antimicrobial therapy achieves eradication in approximately 50% of cases.
  • No ideal therapeutic regimen is currently available.

Conclusions:

  • *C. pylori* is a confirmed human pathogen contributing to gastroduodenal pathology.
  • Further research is needed to develop more effective therapeutic strategies.
  • Antimicrobial therapy is reserved for symptomatic patients after initial H2-receptor antagonist treatment.

Related Experiment Videos